Qi Cao

机构：Manchester Metropolitan University, Zibo Vocational Institute, University of British Columbia, Peking University, Peking University Cancer Hospital, Canada's Michael Smith Genome Sciences Centre, Peking University International Hospital, Obstetrics and Gynecology Hospital of Fudan University, Henan Medical University · ORCID：0000-0001-6571-0095

发表论文 61 篇 · 总被引 2807 次 · h-index 24

代表论文

• Liver tumour immune microenvironment subtypes and neutrophil heterogeneity (2022 · Nature · 被引 999)
• Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma (2024 · Cancer Cell · 被引 66)
• Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma (2024 · The Journal of Experimental Medicine · 被引 29)
• Development of a 18 F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer (2023 · Journal of Medicinal Chemistry · 被引 23)
• Study on the regulatory effect of leech peptide HE-D on macrophages in atherosclerosis by transcriptome sequencing (2022 · Journal of Ethnopharmacology · 被引 12)
• On the origin, evolution, and maintenance of RNA editing (2025 · Nucleic Acids Research · 被引 11)